Literature DB >> 1616327

Outcome of patients with systemic rheumatic disease admitted to medical intensive care units.

B Godeau1, A Boudjadja, J F Dhainaut, B Schlemmer, C Chastang, F Brunet, J R Le Gall.   

Abstract

The outcome of patients admitted to intensive care units is known to be influenced by such factors as age, previous health status, severity of disease, and diagnosis. To estimate the outcome of such patients with systemic rheumatic diseases and to determine if the severity of these diseases unfavourably influences the prognosis at the time of admission to a medical intensive care unit, the clinical courses of all patients with systemic rheumatic disease admitted to two medical intensive care units between January 1978 and December 1988 were studied retrospectively. Sixty nine patients with systemic lupus erythematosus (n = 16), necrotising vasculitis (n = 19), rheumatoid arthritis (n = 19), and other systemic rheumatic diseases (n = 15) were included. The mean (SD) age on admission into the medical intensive care unit was 53 (17) years and the mean simplified acute physiological score was 12 (5.5). The principal diagnoses on admission were infectious complications (29/69 patients) and acute exacerbation of the systemic rheumatic disease (19/69 patients). The death rate in the medical intensive care unit was 33% (23/69 patients) and was similar to that of a non-selected population with comparable simplified acute physiological score. The death rate in hospital was 42% (29/69 patients). Infection was the main cause of death in the medical intensive care unit (19/23 patients) and the infection was mainly acquired in the unit. Only the simplified acute physiological score on admission was a statistically significant prognostic factor: the simplified acute physiological score in patients who died was 15 (5.2) v 9.9 (4.7) for survivors. Long term outcome analysis showed that 83% (33/40 patients) of patients were still alive after admission to the medical intensive care unit with a follow up time between two months and nine years (mean 38 months). The death rate was relatively high and was mainly due to nosocomial infections. It was not different, however, from that of nonselected patients and the long term prognosis was highly favourable. This shows that the complications are often reversible, particularly infectious applications, and justifies admission to the medical intensive care unit of this group of patients.

Entities:  

Mesh:

Year:  1992        PMID: 1616327      PMCID: PMC1005695          DOI: 10.1136/ard.51.5.627

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Nosocomial infection and fatality in medical and surgical intensive care unit patients.

Authors:  D E Craven; L M Kunches; D A Lichtenberg; N R Kollisch; M A Barry; T C Heeren; W R McCabe
Journal:  Arch Intern Med       Date:  1988-05

3.  A simplified acute physiology score for ICU patients.

Authors:  J R Le Gall; P Loirat; A Alperovitch; P Glaser; C Granthil; D Mathieu; P Mercier; R Thomas; D Villers
Journal:  Crit Care Med       Date:  1984-11       Impact factor: 7.598

4.  Prognosis in acute organ-system failure.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

5.  Is intensive care justified for patients with haematological malignancies?

Authors:  F Brunet; J J Lanore; J F Dhainaut; F Dreyfus; J F Vaxelaire; S Nouira; T Giraud; A Armaganidis; J F Monsallier
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

6.  Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms.

Authors:  D B Hellmann; M Petri; Q Whiting-O'Keefe
Journal:  Medicine (Baltimore)       Date:  1987-09       Impact factor: 1.889

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 8.  Complications in the ventilated patient.

Authors:  R M Strieter; J P Lynch
Journal:  Clin Chest Med       Date:  1988-03       Impact factor: 2.878

9.  Nosocomial infections in the immunocompromised adult.

Authors:  L S Young
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

10.  Survival, prognosis, and causes of death in rheumatoid arthritis.

Authors:  D M Mitchell; P W Spitz; D Y Young; D A Bloch; D J McShane; J F Fries
Journal:  Arthritis Rheum       Date:  1986-06
View more
  12 in total

1.  Outcome of patients with connective tissue disease requiring intensive care for respiratory failure.

Authors:  Jinwoo Lee; Jae-Joon Yim; Seok-Chul Yang; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Eun Young Lee; Eun Bong Lee; Yeong Wook Song; Sang-Min Lee
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

2.  Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  F M K Williams; S Chinn; G R V Hughes; R M Leach
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

3.  Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit.

Authors:  Mickaël Moreels; Christian Mélot; Marc Leeman
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

4.  In-ICU-acquired infections in flare-up systemic rheumatic disease patients receiving immunosuppressant.

Authors:  Florence Assan; Pierre Bay; Alexis Mathian; Guillaume Hekimian; Nicolas Bréchot; Paul Quentric; Quentin Moyon; Matthieu Schmidt; Fleur Cohen-Aubart; Julien Haroche; Zahir Amoura; Charles-Edouard Luyt; Alain Combes; Marc Pineton de Chambrun
Journal:  Clin Rheumatol       Date:  2022-05-10       Impact factor: 3.650

Review 5.  Patients with systemic rheumatic diseases admitted to the intensive care unit: what the rheumatologist needs to know.

Authors:  Mohanned Mustafa; Easwaradhas Gladston Chelliah; Michael Hughes
Journal:  Rheumatol Int       Date:  2018-03-16       Impact factor: 2.631

6.  [Outcome of intensive medical care for inflammatory rheumatic diseases].

Authors:  L A Rütter; S Rütter; M Winkler; G Keyßer
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

Review 7.  Diagnosis and management of infectious complications of childhood rheumatic diseases.

Authors:  Rhina D Castillo; Wendy De la Pena; Katherine A B Marzan
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

8.  Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis.

Authors:  Santiago Bernal-Macías; Benjamín Reyes-Beltrán; Nicolás Molano-González; Daniel Augusto Vega; Claudia Bichernall; Luis Aurelio Díaz; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Lupus Sci Med       Date:  2015-12-01

9.  The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU).

Authors:  Federico Biscetti; Angela Carbonella; Federico Parisi; Silvia Laura Bosello; Franco Schiavon; Roberto Padoan; Elisa Gremese; Gianfranco Ferraccioli
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

10.  Factors Associated with Mortality in Patients with Autoimmune Diseases Admitted to the Intensive Care Unit in Bogota, Colombia.

Authors:  Jorge Armando Carrizosa; Jorge Aponte; Diego Cartagena; Ricard Cervera; Maria Teresa Ospina; Alexander Sanchez
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.